Perrigo Co PLC (PRGO)
29.83
-0.27
(-0.90%)
USD |
NYSE |
May 17, 16:00
29.83
0.00 (0.00%)
After-Hours: 20:00
Perrigo Enterprise Value: 7.480B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 7.480B |
| May 16, 2024 | 7.517B |
| May 15, 2024 | 7.534B |
| May 14, 2024 | 7.543B |
| May 13, 2024 | 7.613B |
| May 10, 2024 | 7.600B |
| May 09, 2024 | 7.643B |
| May 08, 2024 | 7.655B |
| May 07, 2024 | 7.524B |
| May 06, 2024 | 7.971B |
| May 03, 2024 | 7.884B |
| May 02, 2024 | 7.920B |
| May 01, 2024 | 7.898B |
| April 30, 2024 | 7.866B |
| April 29, 2024 | 7.886B |
| April 26, 2024 | 7.767B |
| April 25, 2024 | 7.676B |
| April 24, 2024 | 7.671B |
| April 23, 2024 | 7.570B |
| April 22, 2024 | 7.511B |
| April 19, 2024 | 7.612B |
| April 18, 2024 | 7.495B |
| April 17, 2024 | 7.508B |
| April 16, 2024 | 7.498B |
| April 15, 2024 | 7.521B |
| Date | Value |
|---|---|
| April 12, 2024 | 7.547B |
| April 11, 2024 | 7.677B |
| April 10, 2024 | 7.713B |
| April 09, 2024 | 7.806B |
| April 08, 2024 | 7.742B |
| April 05, 2024 | 7.694B |
| April 04, 2024 | 7.701B |
| April 03, 2024 | 7.643B |
| April 02, 2024 | 7.683B |
| April 01, 2024 | 7.791B |
| March 31, 2024 | 7.801B |
| March 28, 2024 | 7.684B |
| March 27, 2024 | 7.585B |
| March 26, 2024 | 7.496B |
| March 25, 2024 | 7.524B |
| March 22, 2024 | 7.566B |
| March 21, 2024 | 7.602B |
| March 20, 2024 | 7.564B |
| March 19, 2024 | 7.420B |
| March 18, 2024 | 7.389B |
| March 15, 2024 | 7.438B |
| March 14, 2024 | 7.505B |
| March 13, 2024 | 7.526B |
| March 12, 2024 | 7.462B |
| March 11, 2024 | 7.468B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.882B
Minimum
May 09 2022
11.29B
Maximum
Feb 25 2020
8.581B
Average
8.606B
Median
Enterprise Value Benchmarks
| Alkermes PLC | 3.632B |
| Endo International PLC (DELISTED) | -777.78M |
| Jazz Pharmaceuticals PLC | 10.76B |
| Medtronic PLC | 131.10B |
| Iterum Therapeutics PLC | 25.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.00M |
| Revenue (Quarterly) | 1.082B |
| Total Expenses (Quarterly) | 1.093B |
| EPS Diluted (Quarterly) | 0.01 |
| Gross Profit Margin (Quarterly) | 33.06% |
| Profit Margin (Quarterly) | 0.18% |
| Earnings Yield | -0.23% |
| Operating Earnings Yield | 5.42% |
| Normalized Earnings Yield | 3.100 |